Francisco Javier
Escalada San Martín
Consultor Médico
![Foto de Francisco Javier](/img/nophoto.png)
![Foto de Clínica Universitaria de Navarra](/img/noimage_org.png)
Clínica Universitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (19)
2024
-
Cardiometabolic risk stratification using a novel obesity phenotyping system based on body adiposity and waist circumference
European Journal of Internal Medicine, Vol. 124, pp. 54-60
2023
-
A survey on the perception of the specialty of Endocrinology and Nutrition among students preparing for the entrance exam for medical specialty training in Spain
Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 4, pp. 240-244
-
Glycaemic Control and Weight Reduction: A Narrative Review of New Therapies for Type 2 Diabetes
Diabetes Therapy, Vol. 14, Núm. 11, pp. 1771-1784
-
Is the Spanish type 1 diabetes mellitus registry really necessary?
Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 10, pp. 617-618
2021
-
Endocrine disorders and psychiatric manifestations
Endocrinology (Switzerland) (Springer Science and Business Media Deutschland GmbH), pp. 311-345
-
Obesity and COVID-19. A necessary position statement
Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 8, pp. 573-576
-
Portfolio of services in Endocrinology and Nutrition. 2020 update
Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 8, pp. 577-588
-
Portfolio of services in Endocrinology and Nutrition. 2020 update
Endocrinologia, diabetes y nutricion, Vol. 68, Núm. 8, pp. 577-588
2020
-
Clinical Approach to Flash Glucose Monitoring: An Expert Recommendation
Journal of Diabetes Science and Technology
-
Reduced Hypoglycemia Risk in Type 2 Diabetes Patients Switched to/Initiating Insulin Glargine 300 vs 100 U/ml: A European Real-World Study
Advances in Therapy, Vol. 37, Núm. 9, pp. 3863-3877
2019
-
Impact of bariatric surgery on bone tissue
Endocrinologia, Diabetes y Nutricion
2018
-
Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis
Diabetes Therapy, Vol. 9, Núm. 5, pp. 2043-2053
-
COSMIC project: Consensus on the objectives of the metabolic syndrome in clinic
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 11, pp. 683-697
-
Consensus on insulin treatment in type 2 diabetes
Endocrinologia, Diabetes y Nutricion, Vol. 65, pp. 1-8
-
Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild-to-moderate renal impairment
Diabetes, Obesity and Metabolism, Vol. 20, Núm. 12, pp. 2860-2868
-
High Body Adiposity Drives Glucose Intolerance and Increases Cardiovascular Risk in Normoglycemic Subjects
Obesity, Vol. 26, Núm. 4, pp. 672-682
2017
-
Review of basal-plus insulin regimen options for simpler insulin intensification in people with Type 2 diabetes mellitus
Diabetic Medicine, Vol. 34, Núm. 9, pp. 1193-1204
-
Tratamiento del hígado graso no alcohólico en la diabetes mellitus tipo 2: ¿por qué tratar el hígado graso no alcohólico?
ENDOCRINOLOGIA, DIABETES Y NUTRICION, Vol. 1, Núm. S2, pp. 21-27